A New Paradigm for KIM-PTP Drug Discovery: Identification of Allosteric Sites with Potential for Selective Inhibition Using Virtual Screening and LEI Analysis

Int J Mol Sci. 2021 Nov 11;22(22):12206. doi: 10.3390/ijms222212206.

Abstract

The kinase interaction motif protein tyrosine phosphatases (KIM-PTPs), HePTP, PTPSL and STEP, are involved in the negative regulation of mitogen-activated protein kinase (MAPK) signalling pathways and are important therapeutic targets for a number of diseases. We have used VSpipe, a virtual screening pipeline, to identify a ligand cluster distribution that is unique to this subfamily of PTPs. Several clusters map onto KIM-PTP specific sequence motifs in contrast to the cluster distribution obtained for PTP1B, a classic PTP that mapped to general PTP motifs. Importantly, the ligand clusters coincide with previously reported functional and substrate binding sites in KIM-PTPs. Assessment of the KIM-PTP specific clusters, using ligand efficiency index (LEI) plots generated by the VSpipe, ascertained that the binders in these clusters reside in a more drug-like chemical-biological space than those at the active site. LEI analysis showed differences between clusters across all KIM-PTPs, highlighting a distinct and specific profile for each phosphatase. The most druggable cluster sites are unexplored allosteric functional sites unique to each target. Exploiting these sites may facilitate the delivery of inhibitors with improved drug-like properties, with selectivity amongst the KIM-PTPs and over other classical PTPs.

Keywords: VSpipe; computational screening; drug discovery; hematopoietic protein tyrosine phosphatase (HePTP); kinase interaction motif protein tyrosine phosphatases (KIM-PTPs); ligand efficiency indices (LEIs); phosphatase inhibitors; protein phosphatases (PPases); protein tyrosine phosphatase SL (PTP-SL); striatum-enriched protein tyrosine phosphatase (STEP); virtual screening (VS).

MeSH terms

  • Allosteric Site
  • Drug Delivery Systems*
  • Drug Discovery*
  • Enzyme Inhibitors / chemistry*
  • Humans
  • Ligands
  • MAP Kinase Signaling System*
  • Protein Tyrosine Phosphatases* / antagonists & inhibitors
  • Protein Tyrosine Phosphatases* / chemistry

Substances

  • Enzyme Inhibitors
  • Ligands
  • Protein Tyrosine Phosphatases